Member, Oversight Committee
Mr. Kroslowitz currently serves as the President and CEO of Berlin Heart Inc. and is responsible for expanding the company’s business interests in the US, Canada, and Mexico, and is currently focused on evaluating new business opportunities for potential funding and/or acquisition. Previously, Bob served as Senior Vice President of Clinical Affairs for the company and was responsible for successfully bringing the first ever viable long term circulatory support option for the pediatric population through the regulatory approval process in the US, Canada, and Mexico. Prior to joining Berlin Heart Bob held leadership and consulting roles in other medical device companies including NovoSci, Maquet, Jostra, Terumo, and Sorin. Bob is passionate about fostering the development of medical devices specifically for the pediatric population and often speaks and serves on panels related to this topic. He has commercialized several pediatric specific devices, including the EXCOR Pediatric Ventricular Assist Device System, the only viable long term circulatory support system available worldwide that was developed specifically for the pediatric population. He also led the effort to commercialize the Jostra HL-20 Heart Lung Machine for use during pediatric open heart surgery, Jostra’s Quadrox oxygenation system for short term pulmonary support, the Jostra HL-30 temperature control system, the RotaFlow Continuous Flow Centrifugal Blood Pump for short term use in ECMO and left, right or biventricular circulatory support in the pediatric population. In addition to the products identified above, Mr. Kroslowitz was involved in the design and development of a novel pediatric cardioplegia system, a pediatric arterial line filtration system, a neonatal oxygenation system, and a neonatal perfusion system that allowed for the elimination of blood in cardiopulmonary bypass system for infants. In addition to contributing to the research, development and commercialization of pediatric medical devices, Mr. Kroslowitz managed for some time the Pediatric Cardiac Surgery Research Lab at Columbia Presbyterian Medical Center in New York where he oversaw the initial pre-clinical work for some of the products listed above. He has also participated on panels related to pediatric device development and commercialization with representatives from the medical community and the governmental regulatory bodies, speaks frequently on topics related to pediatric device development, approval and commercialization, and has served as an advisor to several early stage medical device companies.